Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Cairo

Showing results (171-180 of 268) with videos related to

Pageof 27
Sort By:
Journal for Immunotherapy of Cancer|September 12, 2024
Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapyWen Luo, Hai Hoang, Hongwen Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2004
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipientsIfeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcomaPatrick J Stiff, Manza-A Agovi, Karen H Antman, et al.
British Journal of Haematology|October 20, 2011
Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortalityDiane George, Nader Kim El-Mallawany, Zhezhen Jin, et al.
Oncotarget|January 27, 2018
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatmentAradhana Awasthi, Delphine C M Rolland, Janet Ayello, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2012
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipientsPrakash Satwani, Zhezhen Jin, Deirdre Duffy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipientsPrakash Satwani, Leah Baldinger, Jason Freedman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Plos One|July 15, 2015
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk SarcomasXin Huang, Haein Park, Joseph Greene, et al.
Pediatric Blood & Cancer|March 14, 2014
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemiaCatherine McGuinn, Mark B Geyer, Zhezhen Jin, et al.
Pageof 27

Showing results (171-180 of 268) with videos related to

Sort By:
Pageof 27
Journal for Immunotherapy of Cancer|September 12, 2024
Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapyWen Luo, Hai Hoang, Hongwen Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2004
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipientsIfeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcomaPatrick J Stiff, Manza-A Agovi, Karen H Antman, et al.
British Journal of Haematology|October 20, 2011
Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortalityDiane George, Nader Kim El-Mallawany, Zhezhen Jin, et al.
Oncotarget|January 27, 2018
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatmentAradhana Awasthi, Delphine C M Rolland, Janet Ayello, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2012
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipientsPrakash Satwani, Zhezhen Jin, Deirdre Duffy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipientsPrakash Satwani, Leah Baldinger, Jason Freedman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Plos One|July 15, 2015
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk SarcomasXin Huang, Haein Park, Joseph Greene, et al.
Pediatric Blood & Cancer|March 14, 2014
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemiaCatherine McGuinn, Mark B Geyer, Zhezhen Jin, et al.
Pageof 27